PubRank

Jhingook Kim

Author PubWeight™ 172.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008 9.29
2 Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012 6.77
3 The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2015 2.95
4 Solitary fibrous tumors of the pleura: surgical outcome and clinical course. Ann Thorac Surg 2005 2.46
5 Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 2008 2.31
6 A comparative analysis of video-assisted mediastinoscopy and conventional mediastinoscopy. Ann Thorac Surg 2011 2.23
7 Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008 2.17
8 Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol 2015 2.17
9 The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004 1.99
10 Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Ann Surg 2013 1.76
11 Video-assisted thoracic surgery lobectomy: single institutional experience with 704 cases. Ann Thorac Surg 2010 1.68
12 Descending necrotizing mediastinitis: a minimally invasive approach using video-assisted thoracoscopic surgery. Ann Thorac Surg 2004 1.63
13 Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2003 1.55
14 Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun 2011 1.54
15 Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010 1.47
16 Dry pleural dissemination in non-small cell lung cancer: prognostic and diagnostic implications. Radiology 2011 1.46
17 Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J Clin Oncol 2013 1.40
18 Pleural recurrence and long-term survival after thoracotomy and thoracoscopic lobectomy. Ann Thorac Surg 2013 1.40
19 Concurrent endobronchial carcinoid tumor and sarcoidosis. Intern Med 2010 1.40
20 Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res 2007 1.38
21 Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010 1.35
22 Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma--a single-institutional experience. Eur J Cardiothorac Surg 2012 1.32
23 Primary salivary gland-type lung cancer: surgical outcomes. Lung Cancer 2010 1.32
24 Sixteen cases of sclerosing hemangioma of the lung including unusual presentations. J Korean Med Sci 2004 1.27
25 Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget 2013 1.27
26 High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol 2012 1.26
27 Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005 1.25
28 Unplanned conversion to thoracotomy during video-assisted thoracic surgery lobectomy does not compromise the surgical outcome. World J Surg 2011 1.22
29 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 1.21
30 Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis 2006 1.20
31 Discovery of ALK-PTPN3 gene fusion from human non-small cell lung carcinoma cell line using next generation RNA sequencing. Genes Chromosomes Cancer 2012 1.19
32 Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 2004 1.18
33 Treatment of inflammatory myofibroblastic tumor of the chest: the extent of resection. Ann Thorac Surg 2007 1.15
34 Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010 1.15
35 Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2013 1.14
36 Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients. AJR Am J Roentgenol 2007 1.13
37 Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. PLoS Genet 2011 1.12
38 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 1.12
39 Radiographic and CT findings in complications following pulmonary resection. Radiographics 2002 1.12
40 Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung. Oncology 2011 1.10
41 Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer 2012 1.09
42 Factors determining successful computed tomography-guided localization of lung nodules. J Thorac Cardiovasc Surg 2011 1.09
43 Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer 2009 1.08
44 A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers. PLoS One 2013 1.08
45 Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010 1.08
46 Pulmonary artery sarcoma mimicking pulmonary thromboembolism: integrated FDG PET/CT. AJR Am J Roentgenol 2007 1.05
47 Pulmonary inflammatory pseudotumor (inflammatory myofibroblastic tumor): CT features with pathologic correlation. J Comput Assist Tomogr 2005 1.04
48 Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 2004 1.04
49 Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study. Radiology 2006 1.03
50 Airway leiomyoma: imaging findings and histopathologic comparisons in 13 patients. AJR Am J Roentgenol 2007 1.02
51 Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer 2008 1.01
52 The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol 2013 1.00
53 Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol 2003 0.99
54 Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol 2009 0.99
55 Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer. J Thorac Oncol 2010 0.99
56 Surgical correction of postpneumonectomy-like syndrome in a patient with a tuberculosis-destroyed lung. J Thorac Cardiovasc Surg 2008 0.98
57 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 0.98
58 Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications. Radiology 2012 0.97
59 Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. J Thorac Oncol 2009 0.97
60 The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet 2011 0.96
61 ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. Cancer 2008 0.96
62 Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 2005 0.94
63 Results of interventional bronchoscopy in the management of postoperative tracheobronchial stenosis. J Thorac Cardiovasc Surg 2012 0.94
64 A multicellular spheroid formation and extraction chip using removable cell trapping barriers. Lab Chip 2010 0.94
65 Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers. Radiology 2012 0.93
66 Clinicopathological analysis of 21 thymic neuroendocrine tumors. Korean J Pathol 2012 0.93
67 Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003 0.92
68 Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. J Thorac Oncol 2009 0.91
69 Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J Thorac Cardiovasc Surg 2007 0.91
70 CT scan features as predictors of patient outcome after bronchial intervention in endobronchial TB. Chest 2010 0.91
71 A novel fusion of TPR and ALK in lung adenocarcinoma. J Thorac Oncol 2014 0.91
72 Intrapulmonary bronchogenic cyst: CT and pathologic findings in five adult patients. AJR Am J Roentgenol 2002 0.90
73 Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy. Ann Surg Oncol 2014 0.90
74 Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci 2007 0.90
75 The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging. J Thorac Imaging 2003 0.90
76 External tracheal stabilization technique for acquired tracheomalacia using a tailored silicone tube. Ann Thorac Surg 2012 0.90
77 Treatment of congenital cystic adenomatoid malformation: should lobectomy always be performed? Ann Thorac Surg 2008 0.90
78 Analysis of 1,067 cases of video-assisted thoracic surgery lobectomy. Korean J Thorac Cardiovasc Surg 2011 0.89
79 Long-term results of surgical treatment in benign bronchoesophageal fistula. J Thorac Cardiovasc Surg 2007 0.88
80 Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer. Lung Cancer 2006 0.88
81 HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. J Thorac Oncol 2014 0.88
82 Heterotopic supradiaphragmatic liver combined with intralobar pulmonary sequestration. Ann Thorac Surg 2008 0.87
83 High dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancer. Yonsei Med J 2012 0.87
84 RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer. Int J Cancer 2005 0.87
85 Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery. Lung Cancer 2012 0.87
86 Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2010 0.87
87 Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1. EMBO Rep 2012 0.86
88 Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci 2008 0.86
89 Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway. Anticancer Res 2013 0.86
90 CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol Rep 2012 0.85
91 Protein profiling in human sera for identification of potential lung cancer biomarkers using antibody microarray. Proteomics 2009 0.85
92 Repeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessment. Ann Surg Oncol 2013 0.85
93 Thoracic epithelioid hemangioendothelioma: imaging and pathologic features. Acta Radiol 2011 0.85
94 Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer. Ann Thorac Surg 2013 0.85
95 FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications. Korean J Radiol 2008 0.85
96 Effect of different particles on cell proliferation in polymer scaffolds using a solvent-casting and particulate leaching technique. ASAIO J 2002 0.84
97 Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Anticancer Res 2014 0.84
98 A modified Nuss procedure for late adolescent and adult pectus excavatum. World J Surg 2010 0.84
99 Thymoma of the middle mediastinum. Korean J Thorac Cardiovasc Surg 2012 0.84
100 Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes. Am J Surg Pathol 2015 0.84
101 Treatment outcomes of patients with adenoid cystic carcinoma of the airway. Lung Cancer 2010 0.84
102 Metaplastic ossification in the cartilage of the bronchus of a patient with chronic multi-drug resistant tuberculosis: a case report. J Med Case Rep 2010 0.84
103 A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors. J Thorac Oncol 2013 0.83
104 Carinal resection and reconstruction in thoracic malignancies. J Surg Oncol 2014 0.83
105 Surgical treatment for pulmonary artery sarcoma. Eur J Cardiothorac Surg 2008 0.83
106 Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach. Medicine (Baltimore) 2015 0.83
107 Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population. Ann Surg 2012 0.82
108 Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model. Clin Cancer Res 2011 0.82
109 Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography. J Thorac Oncol 2011 0.82
110 Giant cystic chondroid hamartoma. J Korean Med Sci 2005 0.82
111 Lymphoepithelioma-like carcinoma in the trachea: report of a case. Surg Today 2007 0.82
112 Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture. Anticancer Res 2013 0.82
113 Type B thymoma: is prognosis predicted only by World Health Organization classification? J Thorac Cardiovasc Surg 2009 0.82
114 Prediction of lymph node metastasis using the combined criteria of helical CT and mRNA expression profiling for non-small cell lung cancer. Lung Cancer 2008 0.82
115 Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 2007 0.82
116 Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma. J Thorac Oncol 2015 0.82
117 Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features. J Korean Med Sci 2009 0.81
118 Diffusion-weighted MRI for distinguishing non-neoplastic cysts from solid masses in the mediastinum: problem-solving in mediastinal masses of indeterminate internal characteristics on CT. Eur Radiol 2013 0.81
119 Tracheal stenosis depends on the extent of cartilaginous injury in experimental canine model. Exp Lung Res 2003 0.81
120 Successful treatment of Mycobacterium celatum pulmonary disease in an immunocompetent patient using antimicobacterial chemotherapy and combined pulmonary resection. Yonsei Med J 2010 0.81
121 Clinical characteristics and feasibility of thoracoscopic approach for congenital cystic adenomatoid malformation in adults. Eur J Cardiothorac Surg 2007 0.81
122 Surgical resection of recurrent lung cancer in patients following curative resection. J Korean Med Sci 2006 0.81
123 En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg 2011 0.81
124 The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 2014 0.80
125 Primary gastric cancer in an oesophageal gastric graft after oesophagectomy. Eur J Cardiothorac Surg 2011 0.80
126 Use of omentum as an in vivo cell culture system in tissue engineering. ASAIO J 2004 0.80
127 Stage III thymic epithelial neoplasms are not homogeneous with regard to clinical, pathological, and prognostic features. J Thorac Oncol 2009 0.80
128 Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes. Acad Radiol 2012 0.80
129 Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival. J Surg Oncol 2007 0.80
130 Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol 2005 0.79
131 Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thorac Imaging 2002 0.79
132 Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer. J Surg Res 2007 0.79
133 Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type. J Korean Med Sci 2004 0.79
134 Clinical application of the Natural Y stent in the management of benign carinal stenosis. Ann Thorac Surg 2009 0.79
135 Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype. Br J Haematol 2013 0.78
136 Fgfbp1 is essential for the cellular survival during zebrafish embryogenesis. Mol Cells 2010 0.78
137 Optimized serological isolation of lung-cancer-associated antigens from a yeast surface-expressed cDNA library. J Microbiol Biotechnol 2007 0.78
138 Comparison of natural and Dumon airway stents for the management of benign tracheobronchial stenoses. Respirology 2006 0.78
139 Employment status and work-related difficulties in lung cancer survivors compared with the general population. Ann Surg 2014 0.78
140 Main bronchial reconstruction with sparing of pulmonary parenchyma for benign diseases. J Korean Med Sci 2006 0.78
141 Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer? Lung Cancer 2006 0.78
142 Predicting recurrence using the clinical factors of patients with non-small cell lung cancer after curative resection. J Korean Med Sci 2009 0.78
143 Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur J Cardiothorac Surg 2002 0.78
144 Bronchial schwannomas: clinicopathologic analysis of 7 cases. Korean J Pathol 2013 0.77
145 Differential gene expression during colon-to-lung metastasis. Oncol Rep 2011 0.77
146 Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor? Cancer Res Treat 2012 0.77
147 Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer. World J Surg 2012 0.77
148 Pulmonary adenocarcinoma with heterotopic ossification. J Korean Med Sci 2009 0.77
149 Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer. J Cancer Res Clin Oncol 2006 0.77
150 Factors affecting tissue culture and transplantation using omentum. ASAIO J 2010 0.76
151 Unilateral usual interstitial pneumonia associated with sarcoma of the pulmonary artery. AJR Am J Roentgenol 2007 0.76
152 The signature from messenger RNA expression profiling can predict lymph node metastasis with high accuracy for non-small cell lung cancer. J Thorac Oncol 2006 0.76
153 VAMP2-NRG1 Fusion Gene is a Novel Oncogenic Driver of Non-Small-Cell Lung Adenocarcinoma. J Thorac Oncol 2015 0.76
154 High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center. J Korean Med Sci 2009 0.75
155 A study of electrochemical biosensor for analysis of three-dimensional (3D) cell culture. Biosens Bioelectron 2012 0.75
156 Surgical treatment of non-small cell lung cancer with isolated synchronous brain metastases. J Korean Med Sci 2006 0.75
157 Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer. J Korean Med Sci 2006 0.75
158 Tropism between hepatic and pulmonary metastases in colorectal cancers. Oncol Rep 2012 0.75
159 Pulmonary mucinous cystadenocarcinoma: report a case and review of CT findings. Korean J Radiol 2013 0.75
160 Optimization for enhancement of signal effectiveness in three-dimensional (3D) cell based electrochemical biosensor. Conf Proc IEEE Eng Med Biol Soc 2011 0.75
161 A pumpless perfusion cell culture cap with two parallel channel layers keeping the flow rate constant. Biotechnol Prog 2012 0.75
162 Validation of the IASLC Residual Tumor Classification in Patients with Stage III-N2 Non-small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery. Ann Surg 2022 0.75
163 The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery. Cancer Res Treat 2003 0.75
164 Establishment and characterization of a lung cancer cell line, SMC-L001, from a lung adenocarcinoma. In Vitro Cell Dev Biol Anim 2014 0.75
165 Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study. Anesth Analg 2016 0.75
166 Effective method for the isolation and proliferation of primary lung cancer cells from patient lung tissues. Biotechnol Lett 2013 0.75